Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP
| Report ID | 195408 |
| Drug Identification Number | 02292262 |
| Brand name | CEFTRIAXONE SODIUM FOR INJECTION BP |
| Common or Proper name | CEFTRIAXONE SODIUM |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTRIAXONE |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10PSOIJ |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-19 |
| Estimated end date | 2023-08-04 |
| Actual end date | 2023-07-17 |
| Shortage status | Resolved |
| Updated date | 2023-07-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-07-18 | English | Compare |
| v5 | 2023-07-17 | French | Compare |
| v4 | 2023-07-17 | English | Compare |
| v3 | 2023-06-20 | English | Compare |
| v2 | 2023-06-19 | French | Compare |
| v1 | 2023-06-19 | English | Compare |
Showing 1 to 6 of 6